secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001104659-23-040268
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma exchanges $8M notes for Series C preferred, issues $2M new note at 25% interest
--------------------------------------------------------------------------------

- Exchanged $8M of 25% Senior Secured Convertible Notes for 8,000 shares of Series C Convertible Voting Preferred Stock.
- Issued a new $2M 25% Senior Secured Convertible Promissory Note due March 28, 2024, convertible at $6.50/share.
- Series C Preferred carries 25% annual dividend, liquidation preference, and voting rights on as-converted basis.
- Exchange exempt from registration under Section 3(a)(9); new note issued under Section 4(a)(2) of Securities Act.
- Filed Certificate of Designation for Series C Preferred with Delaware Secretary of State on March 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000110465923040268/0001104659-23-040268-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000110465923040268/tm2311199d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-040268

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer